Source: https://patents.google.com/patent/US9132230
Timestamp: 2018-02-24 14:13:06
Document Index: 702085941

Matched Legal Cases: ['Application No. 2007282068', 'Application No. 2007282068', 'Application No. 2007282068', 'Application No. 2007282069', 'Application No. 2007282068', 'Application No. 2007282070', 'Application No. 2', 'Application No. 2', 'Application No. 2', 'Application No. 2', 'Application No. 2', 'Application No. 2', 'Application No. 2', 'Application No. 07836379', 'Application No. 07836389', 'Application No. 07797060', 'Application No. 07810948', 'Application No. 07810949', 'Application No. 07836379', 'Application No. 2007282068', 'Application No. 2007282070']

US9132230B2 - Interface for medical infusion pump - Google Patents
US9132230B2
US9132230B2 US13620031 US201213620031A US9132230B2 US 9132230 B2 US9132230 B2 US 9132230B2 US 13620031 US13620031 US 13620031 US 201213620031 A US201213620031 A US 201213620031A US 9132230 B2 US9132230 B2 US 9132230B2
US13620031
US20130012880A1 (en )
This application is a division of application Ser. No. 11/499,240 filed Aug. 3, 2006 which is hereby fully incorporated herein by reference.
Communication media typically embodies computer-readable instructions, data structures, program modules or other data in a modulated data signal such as a carrier wave or other transport mechanism and includes any information delivery media. The term “modulated data signal” refers to a signal that has one or more of its characteristics set or changed in such a manner as to encode information in the signal. By way of example, and not limitation, communication media includes wired media such as a wired network or direct-wired connection, and wireless media such as acoustic, RF, infrared, and other wireless media. Combinations of any of the above should also be included within the scope of computer-readable media. Computer-readable media may also be referred to as computer program product.
FIG. 6B illustrates a second possible embodiment of a library 508. The library 508 contains a number of protocols 510, which, as in FIG. 6A, include patient specific pump parameters 512 a, non-patient specific pump parameters 512 b, and an index 514. The number of protocols 510 included in each library 508 may vary, so the number of protocols 510 in the library 508 of FIG. 6B may be different from the number of protocols in the library shown in 6A. In the embodiment shown, the library 508 contains one protocol 510. Additionally, one or more of the therapy, qualifier, and drug regions in the index 514 can be replaced by other index criteria, such as locations, pump programs, doctor identification, or other indexable criteria capable of referring to a unique pump protocol within the library. In the example shown, the “therapy” region is used to select a pump program, such as a continuous delivery program, an intermittent delivery program, or a specific type of program such as a pain management program. The “qualifier” region is used to select a doctor, and may be the name of a doctor using the infusion pump network of FIG. 5.
The protocol module 712 adds, edits, and defines protocols by associating therapies, qualifiers, and drugs with pump parameters to form libraries of pump protocols for a medical infusion pump. The protocol module 712 allows a user to select a therapy defined in the therapy definition module 718. The protocol module further allows the user to associate a qualifier defined in the qualifier definition module 720 with the selected therapy. For example, one or both of “adults” and “children 5-10 years” qualifiers can be associated with an epidural therapy. The protocol module 712 also associates one or more drugs with each therapy and qualifier combination, indicating that use of the drug is appropriate for that therapy and qualifier. The protocol module 712 guides the user in defining a protocol by assigning default pump parameters to be associated with the selected therapy, qualifier, and drug.
In one embodiment of the administrative software 700, a user of the software 700 defines each protocol included in a library. In defining each protocol, the user assigns the index to the protocol, such as the therapy, qualifier, and drug defined in the modules 708, 710, 712 above. In a second possible embodiment, the administrative software includes a number of default settings or pump parameter modifications used when specific therapies, qualifiers, or drugs are selected. The user selects a therapy, qualifier, and drug to associate with a pump protocol. The administrative software 700 can include instructions dictating that selection of one or more of the therapies, qualifiers, and drugs sets or modifies one or more of the patient specific pump parameters or non-patient specific pump parameters. In one example of this second embodiment, a user setting a drug having a maximum safe consumption rate will trigger the administrative software 700 to preset an acceptable range of programmable delivery rates and a default delivery rate in the protocol, as well as alarms or other non-patient specific pump parameters. In another possible example of this second embodiment, a user setting a qualifier indicating a low age, such as “Children 5-10 years old”, will set or adjust the protocol to result in a low delivery rate and demand dose being incorporated into the protocol, and will set one or more parameters related to alarms for use in a medical infusion pump.
The therapy definition field 1102 corresponds to the therapy definition module 718 of FIG. 7, and includes a therapy listing 1108, a therapy notes field 1110, and control buttons 1112 a-1112 c. The therapy listing 1108 displays the therapies currently defined in the library displayed in the library listing 802. Two example therapies, “Patient Controlled Analgesia” and “Epidural”, are shown in the therapy listing 1108, and are associated with a library named “NeoNatal Intensive Care Unit”. The therapy notes field 1110 contains administrative user-defined notes related to the therapy selected in the therapy listing 1108. The notes relate to a therapy, and include information related to administration of the therapy, such as messages related to dosage, bolus amount, or administration. The therapy notes field 1110 presents administrative user-created notes to convey therapy-specific information to caregivers using or programming the pump. Control buttons 1112 a-1112 c allow a user to add, edit, and delete therapies from the therapy listing 1108 and therapy notes field 1110.
The qualifier definition field 1104 corresponds to the qualifier definition module 720 of FIG. 7, and includes a qualifier listing 1114, a qualifier notes field 1116, and control buttons 1118 a-1118 c. The qualifier definition field 1104 lists the qualifiers associated with the therapy selected from the list shown in the therapy listing 1108. For example, an administrative user might add a “Children 5-10 yrs” entry to the qualifier listing 1114. Each therapy relates to one or more qualifiers, such as a general qualifier, a weight based qualifier, or an age based qualifier. The qualifier notes field 1116 contains notes describing the difference in application of the therapy based on the qualifier selected. In the case of the “Children 5-10 years” qualifier, the qualifier notes field 1116 can indicate a lower than normal dosage to be administered. Notes associated with the qualifier display in the qualifier notes field 1116 only when the qualifier is selected.
FIG. 13 shows a bar code screen 1300 displaying a bar code for a drug defined in the administrative software 700 of FIG. 7. A drug identification code is associated with each drug in the drug listing 1120 of FIG. 11. A drug is selected from among those in the drug listing 1120 of FIG. 11, and the bar code screen 1300 displays upon clicking on the control button 1122 d.
The bar code screen 1300 includes a print preview field 1302, a printer drop down menu 1304, a label information menu 1306, a copies drop down menu 1308, and control buttons 1310 a-1310 c. The print preview field 1302 displays a bar code associated with the selected drug. The printer drop down menu 1304 lists available printers configured to print the bar code. The label information drop down menu 1306 defines the label configuration to which the bar code is directed. The label configuration includes, for example, the size and layout of the label paper. The copies drop down menu 1308 dictates the number of copies of the bar code that are printed. Control buttons 1310 a-1310 c provide printing, cancellation, and help procedures to a user.
FIG. 16 shows the state of the protocol definition user interface 1500 after a therapy is selected in the therapy drop down menu 1502. Notes related to the selected therapy appear in the therapy notes field 1504, and a list of qualifiers associated with the selected therapy appears in the qualifier drop down menu 1506. The notes correspond to the therapy notes entered in the therapy notes field 1110. The list of qualifiers corresponds to the qualifiers associated to the therapy by listing in the qualifier listing 1114. For example, two qualifiers, “Adults & Children over 5 yrs” and “Children 3-5 yrs” can be associated with the “Patient Controlled Analgesia” therapy. When that therapy is selected in the therapy drop down menu 1502, the two associated qualifiers populate the qualifier drop down menu 1506.
FIG. 17 shows the state of the protocol definition interface 1500 after a qualifier is selected in the qualifier drop down menu 1506. Notes related to the qualifier appear in the qualifier notes field 1508, and a list of drugs available within the library or database appears in the drug drop down menu 1510. The notes correspond to changes in the therapy due to the qualifier selected. Continuing the example from FIG. 14, the “Adults & Children over 5 yrs” qualifier is selected. Notes related to customization of the “Patient Controlled Analgesia” therapy based on the selected qualifier are displayed in the qualifier notes field 1508. Furthermore, a list of four drugs/drug concentrations appear in the drug drop down menu 1510, which are the drugs defined and available within the library or database.
The general settings region 1812 includes verification settings 1816 and weight based settings 1818. The verification settings 1816 includes drug verification and caregiver verification settings. Specifically, the verification settings require that a caregiver verifies that the correct drug is provided to the medical infusion pump. The verification settings also require a second caregiver to verify the settings of the medical infusion pump. The weight based settings 1818 set a weight based protocol at a programmable, variable weight limit. By weight based protocol, it is intended that dosage delivery rates, boluses, thresholds, and other delivery parameters change from a “dosage per hour” basis to a “dosage per weight factor” rate, where the weight factor can be on a per unit measure weight basis for the user of the medical infusion pump 102 (i.e. “per kilogram” or other), or based on the user's body surface area, a weight based therapy, or other options.
The continuous rate region 1822 includes a meter, shown as a slider bar 1828 and an indicator 1829. The meter generally has two or more locations, each corresponding to a parameter value that can be programmed in the medical infusion pump. Generally, the positional relationship of the meter indicates the setting of the meter. In a possible embodiment of the slider bar 1828 shown, the indicator 1829 is movable relative to the slider bar 1828 to set a default value, or “initial value” continuous drug delivery rate parameter. In a second possible embodiment, the default value is set using an initial value gauge 1832.
The demand dose region 1824 includes a slider bar 1842 and an indicator 1843. The slider bar and indicator operate in a similar manner to the slider bar 1828 and indicator 1829 in the continuous rate region 1822, but control demand dose settings. Likewise, the demand dose region 1824 includes an initial value gauge 1844, as well as hard limit gauges 1846 and soft limit gauges 1848 setting visible thresholds and triggering alarms as in the continuous rate region 1822. Demand dose options 1852 a-1852 c provide analogous display, editing, and comment options to the user interface options 1838 a-1838 c.
The demand dose lockout region 1826 includes a slider bar 1854 and an indicator 1855, and also includes an initial value gauge 1856, hard limit gauges 1858, and soft limit gauges 1862. Each of these features functions analogously to those discussed above in conjunction with the continuous rate region 1822. The demand dose lockout region also includes lockout options 1864 a-1864 c analogous to the user interface options 1838 a-1838 c.
FIG. 19 shows the parameter user interface 1800 with the drug delivery tab 1810 modified to provide a weight based drug delivery protocol. The modification of the user interface 1800 occurs in the drug delivery tab 1810 upon user selection of the weight based settings 1818 discussed in FIG. 18. The continuous rate region 1822 and demand dose region 1824 are modified to reflect dosage rates on a “per kilogram” or other weight measure basis.
The protocol selection module 2608 selects a protocol for use with a medical infusion pump from the protocols loaded in the user software 2600. The protocol selection module 2608 guides the user through selection of a therapy, qualifier, and drug combination defined to be a protocol by the administrative software. The protocol selection module 2608 includes a therapy selection module 2614, a qualifier selection module 2616, and a drug selection module 2618 for this purpose. The therapy selection module 2416 selects a therapy to be administered by the drug infusion pump 102. The therapy is one of the therapies included in the library selected in the library import module 2606. The qualifier selection module 2616 selects a qualifier from those associated with the therapy in the library. The drug selection module 2618 selects a drug associated with the therapy and drug. The protocol selection module 2608 further allows customization of the protocol by allowing a user to modify pump parameters, such as the drug delivery rate, the demand dose, the demand dose lockout, drug delivery limits, and reservoir volume
The therapy selection field 2908 lists the therapies included in the currently loaded library. For example, the two therapies shown are “Epidural” and “Patient Controlled Analgesia”. The therapy notes field displays the notes associated with the selected therapy. In the initial state, the therapy selection field 2908 and therapy notes field 2910 are active, and the qualifier fields 2912, 2914, drug fields 2916, 2918, and continue button 2922 are inactive. No therapy is initially selected in the therapy listing field 2908, so the therapy notes field 2910 remains empty.
FIG. 30 shows the user interface 2900 with the protocol tab 2920 selected and a therapy selected from the therapy selection field 2908. Notes related to the selected therapy appear in the therapy notes field 2910, and the qualifier selection field 2912 and qualifier notes field 2914 activate. A listing of qualifiers associated with the selected therapy appears in the qualifier selection field 2912. The therapy notes shown recite “Epidural Patient Controlled Analgesia” corresponding to the selected therapy, but could contain particular information related to the therapy, such as warnings, descriptions, or other information about application of the therapy. The qualifiers, which appear once the therapy is selected, are shown to include “Adult and Child over 5” and “Child 5 years and under”. No qualifier is initially selected, so the qualifier notes field 2914 remains empty. The drug selection field 2916, drug notes field 2918, and the continue button 2922 remain inactive.
FIG. 31 shows the user interface 2900 with the protocol tab 2920 selected and both a therapy selected from the therapy selection field 2908 and a qualifier selected in the qualifier selection field 2912. Notes related to the qualifier appear in the qualifier notes field 2914, and the drug selection field 2916 and drug notes field 2918 are active. For example, “Adult and Child over 5” is shown to be, and the qualifier notes field 2914 displays specific notes applicable to those patients. A listing of drugs associated with the therapy and qualifier appears in the drug selection field 2916. Three exemplary drug menu listings including “Fentanyl 10 mcg/ml”, “HYDRO Morphone 1 mg/ml” and “Morphine 1 mg/ml” are shown. No drug is initially selected, so the drug notes field 2918 remains empty. The continue button 2922 remains inactive.
The optional hard limit determination operation 3308 determines if the pump settings are outside the “hard limits” set in the administrative software 700. If the pump settings exceed the hard limit (i.e. above the maximum or below the minimum value), operational flow branches “yes” to a hard limit indicator module 3310. If the pump settings do not exceed the hard limit, operational flow branches “no” to a soft limit determination operation 3312.
The soft limit determination operation 3312 determines if the pump settings are outside the “soft limits” set in the administrative software 700. If the pump settings exceed the soft limit, operational flow branches “yes” to a soft limit indicator module 3314. If the pump settings do not exceed the soft limit, operational flow branches “no” to return to the display module 3304.
Referring now to FIGS. 34-35, an exemplary user interface 3400 for customizing pump parameters is shown. The user interface 3400 corresponds to the settings module 2808 of FIG. 28, and operates generally as described in FIG. 33. The user interface 3400 includes a status indicator 3402, a continuous rate region, 3404, a demand dose region 3406, a demand dose lockout region 3408, a timed limit region 3410, and a reservoir region 3412. The user interface 3400 further includes control buttons 3414 a-3414 c.
The regions 3404-3412 correspond to the patient specific pump parameters 512 a of FIG. 5, and can include one or more of continuous rate, demand dose, demand dose lockout, timed limits, reservoir volume, and other patient-specific parameters. Only those patient specific pump parameters that are associated with the selected index of therapy, qualifier, and drug appear in the user interface 3400, and can be as few as one parameter and can incorporate as many parameters as are programmable within a medical infusion pump.
The status indicator 3402 displays the library, therapy, qualifier, and drug which define the protocol loaded by the user software 2600. In the exemplary user interface, the library is an “ICU” library, the therapy selected is “Patient Controlled Analgesia”, the qualifier is “Adult and Child over 5”, and the drug is “Fentanyl 10 mcg/ml”.
The protocol indicator field 3604 displays the current protocol selected, in this case shown as “Patient Controlled Analgesia”, “Adult and Child over 5”, and “Fentanyl 10 mcg/ml”. The confirmation button 3606 sends the pump program, including the settings 3602 a-3602 e for the pump parameters, to the pump.
Referring now to FIG. 39, user software 2600 is again described in which the user interface 2900 of FIGS. 29-32 is shown with the tasks tab 2940 selected. The tasks tab 2940 includes a tasks region 3902 for selection of one or more task options, of which a comparison is displayed when the user selects the “continue” option 3904 shown. Tasks include operations related to maintenance of the pump once in operation. The tasks region 3902 includes a number of pump comparison options, such as a compare pump settings option 3906, a compare pump settings to protocol option 3908, and a change reservoir option 3910. The compare pump settings option 3906 compares the pump settings to the original protocol from which the pump parameters were based. The compare pump settings to protocol option 3908 compares all pump settings for the protocol selected.
providing a protocol including one or more patient specific pump parameters that define one or more operational aspects of the medical infusion pump;
providing a user interface configured to allow user adjustment of at least one of the one or more patient specific pump parameters;
uploading the protocol into the medical infusion pump.
2. The method of claim 1, further comprising providing one or more non-patient specific pump parameters.
3. The method of claim 2, wherein the user interface does not display the one or more non-patient specific pump parameters.
7. The method of claim 1, further comprising displaying the user interface on a display of the medical infusion pump.
US13620031 2006-08-03 2012-09-14 Interface for medical infusion pump Active US9132230B2 (en)
US11499240 US20080126969A1 (en) 2006-08-03 2006-08-03 Interface for medical infusion pump
US13620031 US9132230B2 (en) 2006-08-03 2012-09-14 Interface for medical infusion pump
US14851322 US20160000994A1 (en) 2006-08-03 2015-09-11 Interface for medical infusion pump
US11499240 Division US20080126969A1 (en) 2006-08-03 2006-08-03 Interface for medical infusion pump
US14851322 Continuation US20160000994A1 (en) 2006-08-03 2015-09-11 Interface for medical infusion pump
US20130012880A1 true US20130012880A1 (en) 2013-01-10
US9132230B2 true US9132230B2 (en) 2015-09-15
ID=38996219
US11499240 Abandoned US20080126969A1 (en) 2006-08-03 2006-08-03 Interface for medical infusion pump
US13620031 Active US9132230B2 (en) 2006-08-03 2012-09-14 Interface for medical infusion pump
US14851322 Pending US20160000994A1 (en) 2006-08-03 2015-09-11 Interface for medical infusion pump
US (3) US20080126969A1 (en)
CA (1) CA2659618A1 (en)
EP (1) EP2074540A2 (en)
WO (1) WO2008019016A3 (en)
JP5677321B2 (en) * 2009-02-04 2015-02-25 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Medical devices and methods for providing information for glycemic control
USD769932S1 (en) * 2015-01-20 2016-10-25 Microsoft Corporation Display screen with animated graphical user interface
US20160346468A1 (en) * 2015-05-26 2016-12-01 Zyno Medical, LLC. Medical Pump System For Improved Pain Management
US20170161460A1 (en) * 2015-12-04 2017-06-08 Zyno Medical, LLC. Application Development System for Medical Pumps
US20170258986A1 (en) * 2016-03-11 2017-09-14 Micrel Medical Devices S.A. Pump Infusion System
US20050010258A1 (en) 2003-05-07 2005-01-13 Peterson Les Norman Medical device interface system and method
WO2005056083A2 (en) 2003-12-04 2005-06-23 Smiths Medical Md, Inc. Programming medical pumps with electronic standing order template
EP1647291A1 (en) 2003-07-18 2006-04-19 Nemoto Kyorindo Co., Ltd. Medicine infuser for displaying image of entered infusion condition
WO2007101260A2 (en) 2006-02-28 2007-09-07 Abbott Diabetes Care, Inc. Smart messages and alerts for an infusion delivery and management system
US20130012879A1 (en) 2008-04-01 2013-01-10 Debelser David Software features for medical infusion pump
JPH01282802A (en) * 1988-05-09 1989-11-14 Toshiba Silicone Co Ltd Pressure-sensitive resistance element
JPH0795872B2 (en) * 1989-07-18 1995-10-11 株式会社東芝 Operation system
US6783113B2 (en) * 2002-08-15 2004-08-31 Alfred Stephen Schommer Quarter-turn valve
USD586351S1 (en) * 2005-12-02 2009-02-10 Turner Broadcasting Systems, Inc. (Tbs, Inc.) User interface for a display screen
JP2010503014A (en) * 2006-09-05 2010-01-28 コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ Electrophoretic display device
USD586357S1 (en) * 2007-06-29 2009-02-10 Microsoft Corporation Graphical user interface for a portion of a display screen
US20120172802A1 (en) 2006-08-03 2012-07-05 Blomquist Michael L Interface for medical infusion pump
Application and File History for U.S. Appl. No. 11/499,240, filed Aug. 8, 2006, inventor Blomquist.
Application and File History for U.S. Appl. No. 11/702,922, filed Feb. 5, 2007 inventor Evans.
Application and File History for U.S. Appl. No. 11/702,925, filed Feb. 5, 2007, inventors Evans et al.
Application and File History for U.S. Appl. No. 13/419,138, filed Mar. 13, 2012, inventor Blomquist.
Application and File History for U.S. Appl. No. 13/619,964, filed Sep. 14, 2012, inventors Evans et al.
Australian Examination Report No. 3 for Australian Application No. 2007282068 dated Jun. 17, 2013.
Australian Examination Report No. 3 for Australian Application No. 2007282068 dated Jun. 4, 2013.
Australian Examiner's first report on Australian Application No. 2007282068 dated May 10, 2012.
Australian Examiner's first report on Australian Application No. 2007282069 dated Jul. 11, 2011.
Australian Patent Examination Report No. 2 for Australian Application No. 2007282068 dated Dec. 17, 2012.
Australian Patent Examination Report No. 2 for Australian Application No. 2007282070 dated Nov. 2, 2012.
Canadian Office Action for Canadian Application No. 2,659,485 dated Aug. 22, 2013.
Canadian Office Action for Canadian Application No. 2,659,485 dated Mar. 27, 2014.
Canadian Office Action for Canadian Application No. 2,659,494 dated May 12, 2014.
Canadian Office Action for Canadian Application No. 2,659,616 dated Jun. 6, 2014.
Canadian Office Action for Canadian Application No. 2,659,618 dated Jun. 16, 2014.
Canadian Office Action for Canadian Application No. 2,659,629 dated May 8, 2014.
Communication (Reply to Applicant's Arguments) from Canadian Patent Office for Canadian Application No. 2,659,618 dated Apr. 13, 2015.
Decision to refuse European Application for European Application No. 07836379.3-2201 dated Dec. 18, 2012.
Decision to refuse European Application for European Application No. 07836389.2-2201 dated Dec. 18, 2012.
European Office Communication for European Application No. 07797060.6-2201/2050032 dated Dec. 8, 2010.
European Office Communication for European Application No. 07810948.5-1662 dated Feb. 25, 2013.
European Office Communication for European Application No. 07810949.3-1662 dated Feb. 25, 2013.
European Office Communication for European Application No. 07836379.3-2201/2050037 dated Jul. 18, 2012.
International Search Report and Written Opinion for International Application No. PCT/US2007/017122 dated Feb. 19, 2008.
International Search Report and Written Opinion for International Application No. PCT/US2007/017123 dated Jan. 25, 2008.
Notice of Acceptance for Australian Application No. 2007282068 dated Feb. 11, 2014.
Notice of Acceptance for Australian Application No. 2007282070 dated Oct. 3, 2013.
US20080126969A1 (en) 2008-05-29 application
WO2008019016A2 (en) 2008-02-14 application
US20130012880A1 (en) 2013-01-10 application
US20160000994A1 (en) 2016-01-07 application
EP2074540A2 (en) 2009-07-01 application
WO2008019016A3 (en) 2008-07-10 application
CA2659618A1 (en) 2008-02-14 application
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BLOMQUIST, MICHAEL L.;REEL/FRAME:029003/0171
Free format text: MERGER;ASSIGNOR:SMITHS MEDICAL MD, INC.;REEL/FRAME:029090/0391